Articles related to COVID-19

Statins, although effective at lowering cholesterol, may inadvertently impair immune function by reducing vitamin D synthesis. This opinion piece examines how this could have influenced COVID-19 outcomes, highlighting critical considerations for clinical practice.

Higher telehealth use correlates with increased healthcare utilization and costs, indicating that while telehealth improves access, it may also lead to higher rates of ambulatory care-sensitive hospitalizations.

This study from Cleveland Clinic highlights a counterintuitive trend where higher numbers of COVID-19 vaccine doses could lead to increased risk of infection, underscoring the complexity of immune responses and vaccine effectiveness over time.

Recent systematic reviews suggest a subtle increase in NMOSD and MS risks post-COVID-19 vaccination, primarily affecting genetically susceptible individuals.

Recent research indicates a rise in cancer mortality following the third dose of mRNA COVID-19 vaccines, especially in types linked to estrogen sensitivity. This underscores the need for ongoing surveillance and research into the long-term effects of mRNA vaccines on cancer progression.

Recent research from Brown University suggests that the SARS-CoV-2 spike protein could interfere with cancer treatment efficacy by affecting the p53 gene’s ability to suppress tumor growth and repair DNA.